• Investment Strategy

    Being independent backed by a strong partner

    Being classical early-stage investors, we invest in rapidly growing, technology-oriented enterprises and we are exclusively privately funded. We understand our investment as an entrepreneurial partnership. Make use of our experience and our network of numerous enterprises... »more

  • Zukunftsfonds Heilbronn

    From innovative ideas to well-established enterprises

    Zukunftsfonds Heilbronn invests in young and promising technology enterprises that have the ambition to effect positive change. ZFHN supports innovative ideas from the seed and startup to the expansion phase, all the way to a profitable business.
    The unique success model of ZFHN has been implemented since 2005. Today, the portfolio of Zukunftsfonds comprises more than 15 nationally and internationally operating, rapidly growing enterprises.
    The scheduled constant expansion of the future fund creates synergy effects and advances the establishment of technology clusters as well as the exchange of knowledge within the portfolio. »more

  • Information



    Business Plan

    Download DOC, 78 KB


XENiOS® AG Enrolls First Patient in “SynCor” Clinical Trial of its CE-Marked i-cor® Device to Treat Cardiogenic Shock

Press Release Xenios AG


„XENIOS invests in XOR-Labs Toronto“

Press Release Xenios AG


Successful collaboration with BioGenes

Press Release Greenovation


Study demonstrates i-cor synchronized cardiac assist preserves left ventricular (LV) function compared to continuous-flow ECLS in cardiogenic shock

Press Release Xenios AG